• 名称：NRC-AN-019
• 简介：NRC-AN-019 is an orally administered tyrosine kinase inhibitor (TKI) of the Bcr-Abl protein-tyrosine kinase. NRC-AN-019 is more effective in inhibiting angiogenic potential and proliferation of both MDAMB231 and HTB20/BT474 cells.
• CASNO：879507-25-2
• 分子式：C25H17F6N5O
• 分子量：517.431
• SMILES：CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)NC3=NC=CC(=N3)C4=CN=CC=C4
• 保持条件：at -20°C 3 years Powder
• 同名：AN019, AN 019, NRC-an-019
• 纯度：>98%
• 应用：Bcr-Abl inhibitor
• 作用机制：Inhibitor